Bone Marrow TransplantationTransplantation, AutologousBone MarrowBone Marrow CellsTransplantation, HomologousCombined Modality TherapyHematopoietic Stem CellsHematopoietic Stem Cell TransplantationGraft vs Host DiseaseWhole-Body IrradiationBone Marrow PurgingAntineoplastic Combined Chemotherapy ProtocolsBone and BonesLeukemiaTransplantation ConditioningCyclophosphamideAnemia, AplasticGraft SurvivalHematopoiesisBusulfanTissue DonorsLymphoma, Non-HodgkinTransplantation ChimeraLeukemia, Myeloid, AcuteBone Marrow DiseasesHistocompatibility TestingCarmustineRecurrenceTreatment OutcomeColony-Forming Units AssayRemission InductionHistocompatibilityTime FactorsPrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic NeoplasmsTransplantation, IsogeneicStem Cell TransplantationMice, Inbred C57BLMelphalanImmunosuppressive AgentsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, MyeloidHodgkin DiseaseBone Marrow ExaminationBone RemodelingRadiation ChimeraSurvival AnalysisStem CellsKidney TransplantationImmunosuppressionCytomegalovirus InfectionsEtoposideAcute DiseaseHematologic DiseasesBone Marrow NeoplasmsHepatic Veno-Occlusive DiseaseGraft RejectionRetrospective StudiesAntigens, CD34Liver TransplantationActuarial AnalysisMyelodysplastic SyndromesCyclosporineCell DifferentiationCytarabineT-LymphocytesFollow-Up StudiesSurvival RateGranulocyte Colony-Stimulating FactorLymphocyte DepletionHematopoietic Stem Cell MobilizationDisease-Free SurvivalFlow CytometryHLA AntigensLeukocyte CountGraft vs Host ReactionBone DensityMultiple MyelomaLymphomaCells, CulturedOpportunistic InfectionsCell SeparationImmunocompromised HostThiotepaSevere Combined ImmunodeficiencyGranulocytesChimeraLeukocyte TransfusionSalvage TherapyTransplantation ImmunologyNuclear FamilyLymphocyte TransfusionBone ResorptionFatal OutcomePrognosisBone TransplantationAntibodies, MonoclonalHeart TransplantationVincristineDrug Evaluation